Current concepts in diabetic microvascular dysfunction

被引:16
作者
La Fontaine, Javier
Harkless, Lawrence B.
Davis, Christian E.
Allen, Marque A.
Shireman, Paula K.
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Orthoped, Podiatry Div, San Antonio, TX 78229 USA
[2] Assoc Podiatrist Connecticut, Manchester, CT USA
[3] Sports Med Assoc San Antonio, San Antonio, TX USA
[4] Univ Texas, Hlth Sci Ctr, Dept Surg, Div Vasc Surg, San Antonio, TX 78229 USA
[5] S Texas Vet Healthcare Syst, San Antonio, TX USA
关键词
D O I
10.7547/0960245
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Microvascular dysfunction is an important component of the pathologic processes that occur in diabetic foot disease. The endothelial abnormalities observed in patients with diabetes mellitus are poorly understood, and evidence suggests that endothelial dysfunction could be involved in the pathogenesis of diabetic macroangiopathy and microangiopathy. With the advent of insulin replacement in the early 1900s and increased efforts toward metabolic control of diabetes, long-term complications of this disease have become apparent. These late-term complications are primarily disorders of the vascular system. This article reviews the process of microvascular dysfunction and how it may relate to the pathogenesis of diabetic foot problems.
引用
收藏
页码:245 / 252
页数:8
相关论文
共 73 条
  • [11] BUCALA R, 1999, DRUG DEVELOP RES, V325, P836
  • [12] The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: A placebo-controlled randomized clinical trial
    Caballero, AE
    Saouaf, R
    Lim, SC
    Hamdy, O
    Abou-Elenin, K
    O'Connor, C
    LoGerfo, FW
    Horton, ES
    Veves, A
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2003, 52 (02): : 173 - 180
  • [13] THE RELATIONSHIP OF VASCULAR CHANGES TO METABOLIC FACTORS IN DIABETES-MELLITUS AND THEIR ROLE IN THE DEVELOPMENT OF PERIPHERAL-NERVE COMPLICATIONS
    CAMERON, NE
    COTTER, MA
    [J]. DIABETES-METABOLISM REVIEWS, 1994, 10 (03): : 189 - 224
  • [14] INCREASED SERUM CONCENTRATION OF VON-WILLEBRAND-FACTOR IN NON-INSULIN-DEPENDENT DIABETIC-PATIENTS WITH AND WITHOUT DIABETIC NEPHROPATHY
    CHEN, JW
    GALL, MA
    DECKERT, M
    JENSEN, JS
    PARVING, HH
    [J]. BRITISH MEDICAL JOURNAL, 1995, 311 (7017) : 1405 - 1406
  • [15] Lipid peroxidation in diabetes mellitus
    Davi, G
    Falco, A
    Patrono, C
    [J]. ANTIOXIDANTS & REDOX SIGNALING, 2005, 7 (1-2) : 256 - 268
  • [16] ALBUMINURIA REFLECTS WIDESPREAD VASCULAR DAMAGE - THE STENO HYPOTHESIS
    DECKERT, T
    FELDTRASMUSSEN, B
    BORCHJOHNSEN, K
    JENSEN, T
    KOFOEDENEVOLDSEN, A
    [J]. DIABETOLOGIA, 1989, 32 (04) : 219 - 226
  • [17] EBSKOV B, 1980, PROSTHET ORTHOT INT, V4, P77
  • [18] ALTERED RED AND WHITE BLOOD-CELL RHEOLOGY IN TYPE-II DIABETES
    ERNST, E
    MATRAI, A
    [J]. DIABETES, 1986, 35 (12) : 1412 - 1415
  • [19] ENDOTHELIAL RECEPTOR-MEDIATED BINDING OF GLUCOSE-MODIFIED ALBUMIN IS ASSOCIATED WITH INCREASED MONOLAYER PERMEABILITY AND MODULATION OF CELL-SURFACE COAGULANT PROPERTIES
    ESPOSITO, C
    GERLACH, H
    BRETT, J
    STERN, D
    VLASSARA, H
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (04) : 1387 - 1407
  • [20] Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus
    Fasching, P
    Veitl, M
    Rohac, M
    Streli, C
    Schneider, B
    Waldhausl, W
    Wagner, OF
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (12) : 4313 - 4317